Latest 10-Q quarterly reports

Live Ventures Incorporated announces a Fifth Amendment to its Loan and Security Agreement, extending maturity dates and adjusting facility amounts, alongside its Q2 financial results showing a net loss.

Drugs Made in America Acquisition Corp. reports Q1 2026 net income of $1.97 million, driven by trust account interest, while continuing its search for a business combination.

Sentient Brands Holdings Inc. reported its first quarter 2026 financial results, showing a significant increase in revenue compared to the prior year period, though the company continues to address a substantial accumulated deficit and material weaknesses in internal controls.

Tempest Therapeutics and Factor Bioscience Inc. have entered into a letter agreement to modify payment obligations under their Master Services Agreement, impacting future payments and a prior deposit.

Quantum X Labs Inc. (formerly Viewbix Inc.) filed its Q1 2026 10-Q, detailing a strategic shift towards quantum technology and AI, alongside a decline in digital advertising revenue.

Western Uranium & Vanadium Corp. reports a reduced net loss in Q1 2026 compared to Q1 2025, driven by decreased mining expenditures and administrative costs, while revenues saw a decline.

Aeon Acquisition I Corp. files its quarterly report for the period ending March 31, 2026, detailing its formation activities and preparations for an initial public offering.

Avidia Bancorp, Inc. posted a net income of $6.0 million for the first quarter of 2026, a significant turnaround from the prior year's loss, driven by improved net interest income and reduced expenses.

ReposiTrak, Inc. reported a slight revenue decrease in Q3 2026 compared to the prior year, but saw an increase in net income driven by operational efficiencies and strategic focus on recurring revenue.

Nuo Therapeutics reports a significant revenue increase in Q1 2026 driven by product sales and distribution fees, though the company continues to face substantial doubt regarding its ability to continue as a going concern.

Jupiter Neurosciences reported a wider net loss for Q1 2026, driven by increased general and administrative expenses, while R&D costs decreased.

Bone Biologics Corporation reported a net loss of $765,988 for Q1 2026, with a significant decrease in research and development expenses, while general and administrative costs rose.

K&F Growth Acquisition Corp. II reports increased net income and interest income for Q1 2026, while continuing its search for a business combination target.

Nocera, Inc. reported a significant decrease in revenue and a substantial increase in net loss for the first quarter of 2026, primarily due to a decline in its fish trading business and increased operating expenses.

Armlogi Holding Corp. reported a revenue decrease and a wider net loss for the third quarter ended March 31, 2026, citing shifts in customer order volume and operational adjustments.

Wen Acquisition Corp files its Q1 2026 Form 10-Q, detailing its financial status and ongoing search for a business combination.

Man-AHL Diversified I L.P. reported a net income of $5.27 million for the first quarter of 2026, a significant turnaround from a net loss of $6.86 million in the same period last year.

Intrusion Inc. reported a significant revenue decrease and a wider net loss for the first quarter of 2026, primarily due to delays in a key government contract.

Ashford Hospitality Trust reported a net loss of $63.8 million for the first quarter of 2026, impacted by significant impairment charges and a decrease in hotel revenue.

Inuvo, Inc. reported a significant revenue decrease in Q1 2026 due to a strategic reset in its Legacy Search business, while its Audience Modeling segment showed growth, signaling a pivot towards its AI-driven IntentKey platform.

Agriculture & Natural Solutions Acquisition Corporation reports Q1 2026 results, highlighting continued search for a business combination and managing operational expenses.

CISO Global reported a Q1 2026 net loss of $1.59 million, an improvement from the prior year, despite a 13% decrease in total revenue.

Actelis Networks reports a 33% revenue increase in Q1 2026, but net loss widens due to increased financial expenses and a low-margin deal.

Willow Lane Acquisition Corp. II reports net income of $75,360 for Q1 2026, driven by interest income, as it continues its search for a business combination.

Titan Acquisition Corp reports on its financial condition and results of operations for the quarter ended March 31, 2026, detailing its status as a blank check company seeking a business combination.

Travelzoo reported increased revenue for Q1 2026, driven by a significant rise in membership fees, though advertising and commerce revenue saw a slight decline.

RideNow Group reports a 6% increase in total revenue for Q1 2026, driven by strong powersports vehicle sales, while net loss narrows compared to the prior year.

Lixte Biotechnology Holdings, Inc. reported a net loss of $1.99 million for Q1 2026, with significant increases in R&D and G&A expenses, while cash reserves decreased.

Edesa Biotech reports a significant increase in R&D expenses for Q2 2026, driven by preparations for clinical trials, while net loss widens compared to the prior year period.

Laird Superfood reported a net profit of $1.75 million for Q1 2026, a significant turnaround from a net loss in the prior year, driven by the acquisition of Navitas and increased wholesale sales.